申请人:ADIR ET COMPAGNIE
公开号:US20020052400A1
公开(公告)日:2002-05-02
The invention relates to compounds of formula (I):
1
wherein:
R
1
, R
2
and R
3
are as defined in the description,
X is as defined in the description,
Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or S0
2
,
n is equal to from 0 to 5,
A represents a NR
5
R
6
or CZNR
8
R
9
group.
and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
本发明涉及式(I)的化合物:其中:R1、R2和R3如描述中所定义,X如描述中所定义,Y代表氧原子、硫原子、C(H)q基团、SO或S02,n等于0到5,A代表NR5R6或CZNR8R9基团。含有该化合物的药物在治疗或预防褪黑素失调方面具有有用性。